Cardiovascular risk factors in patients on long-term treatment with nevirapine- or efavirenz-based regimens | Zendy

Paolo Maggi | Zendy; Chiara Bellacosa | Zendy; Valentina Carito | Zendy; Francesco Perilli | Zendy; A. Lillo | Zendy; Anna Rita Volpe | Zendy; G. Trillo | Zendy; Domenico Angiletta | Zendy; Guido Regina | Zendy; Gioacchino Angarano | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cardiovascular risk factors in patients on long-term treatment with nevirapine- or efavirenz-based regimens

Author(s) -

Paolo Maggi,

Chiara Bellacosa,

Valentina Carito,

Francesco Perilli,

A. Lillo,

Anna Rita Volpe,

G. Trillo,

Domenico Angiletta,

Guido Regina,

Gioacchino Angarano

Publication year - 2011

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkq507

Subject(s) - nevirapine , efavirenz , medicine , body mass index , reverse transcriptase inhibitor , cholesterol , gastroenterology , subclinical infection , surgery , endocrinology , immunology , human immunodeficiency virus (hiv) , viral load , antiretroviral therapy

The aim of this study was to evaluate the cardiovascular risk among patients treated for more than 5 years with regimens based on nevirapine or efavirenz.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research